Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04399876	Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer	enrolling by invitation	Phase 1	35	Brigham and Women's HospitalOTHER	1	May 18, 2026	clinicaltrials
NCT07583160	YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer(YS247)	enrolling by invitation	Phase 1	18	Changhai HospitalOTHER	1	May 13, 2026	clinicaltrials